SERAplex NTS

 

SERAplex NTS is a ready-to-use, fully defined serum substitute for the cultivation of suspension cells under serum-free conditions. SERAplex NTS is developed with a unique technology and contains a special 3-dimensional substance release system (3D-SRS) for an optimal support of cells with nutrients and growth stimulants. The sterile solution is added to the culture medium in a final concentration of 10%. It supports the growth of many cell types in an optimum manner.

 

DescriptionSizeProduct numberDatasheet
SERAplex NTS 50 ml
100 ml
500 ml
ST04-95080
ST04-95800
ST04-95850
Adobe PDF file icon 32x32
SERAplex NTS
Pharma Grade
50 ml
100 ml
500 ml
ST04-95080P
ST04-95800P
ST04-95850P
Adobe PDF file icon 32x32
 
SERAplex NTS contains purified proteins, lipids, salts, amino acids, trace elements, and hormones in an optimized formulation and a new 3-dimensional substance release system (3D-SRS). SERAplex NTS contains no growth factors, undefined hydrolysates or peptones. SERAplex NTS Pharma Grade is free of any animal-derived components. Customized formulations (e.g. without hormones and insulin) on request.
SERAplex NTS is suitable for the cultivation of a variety of non-adherent suspension cells under serum-free conditions.
SERAplex NTS can be used for many cell lines to replace FBS. Due to specially selected and pretested raw materials SERAplex NTS batches are very homogeneous. Therefore the complex batch testing known from FBS can be omitted with the use of SERAplex NTS. SERAplex NTS is completely fully defined and contains no growth factors, undefined peptones or hydrolysates. Due to this special formulation the interpretation of results from studies on effects of individually added growth factors is easier and more reliable in serum-free conditions. For cell lines which require specific growth factors these should be added in a concentration as previously used.
This website use cookies to create the most secure and effective website. By continuing to use this website you agree that cookies are used.
More information Ok